Health News

WHEELING, W.Va. (MedPage Today) — Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.

Read more

Filed under: General Health News
Tags: cancer, Drug, General Health News

Related posts

• WFU researchers develop new platinum-based anti-tumor compound (0)
  (Wake Forest University) Researchers in the Department of Chemistry at Wake Forest University in collaboration with colleagues at the Wake Forest University Health Sciences Comprehensive Cancer Center have developed a new class of platinum-based anti-tumor drugs that animal studies have shown to be 10 times more effective than current treatments in destroying certain types of [...]
  
  
• Weizmann Institute scientists discover how cancer cells survive a chemotherapy drug (0)
  (Weizmann Institute of Science) New techniques enabled Weizmann Institute scientists to assess the actions of thousands of proteins in cancer cells and identify those that help some survive a chemotherapy treatment. Read more [tags] General Health News [/tags]
  
  
• Washington Week: SGR Patch, Lots of FDA Action (0)
  WASHINGTON (MedPage Today) -- Congress passed three health-related bills this week and FDA panels weighed in on drugs for thyroid and prostate cancer, a fecal incontinence product, and a weight-loss device. Read more [tags] General Health News [/tags]
  
  
• Washington Week: SGR Patch, FDA Action (0)
  WASHINGTON (MedPage Today) -- Congress passed three health-related bills this week and FDA panels weighed in on drugs for thyroid and prostate cancer, a fecal incontinence product, and a weight-loss device. Read more [tags] General Health News [/tags]
  
  
• Washington Week: New Rule to Stop Big Premium Hikes (0)
  WASHINGTON (MedPage Today) -- The federal government issued a final rule aimed at preventing insurers from drastically raising insurance premiums; an FDA panel recommends new rules to prevent young kids from overdosing on acetaminophen; and the FDA okays a second drug to treat a rare type of pancreatic cancer. Read more [tags] General Health News [/tags]